August 1, 2024Open Access

Diagnostic accuracy of serum biomarkers to identify giant cell arteritis in patients with polymyalgia rheumatica

Key Points

Key points are not available for this paper at this time.

Abstract

Polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) are frequently overlapping conditions. Unlike in GCA, vascular inflammation is absent in PMR. Therefore, serum biomarkers reflecting vascular remodelling could be used to identify GCA in cases of apparently isolated PMR.

Read Full Paperexternally

AIに質問

Bookmark

View Full Paper

Cite This Study

Ramon et al. (Thu,) studied this question.

synapsesocial.com/papers/68e5dc57b6db643587571d71 https://doi.org/https://doi.org/10.1136/rmdopen-2024-004488

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Matrix Metalloproteinase (MMP)-3 Activates MMP-9 Mediated Vascular Smooth Muscle Cell Migration and Neointima Formation in Mice2011 · 150 citations
2Correlation of interleukin‐6 production and disease activity in polymyalgia rheumatica and giant cell arteritis1993 · 343 citations
32022 American College of Rheumatology/EULAR classification criteria for giant cell arteritis2022 · 359 citations
4Clinical relevance of elevated serum thrombomodulin and soluble E-selectin in patients with Wegener's granulomatosis and other systemic vasculitides1996 · 118 citations
5MMP-3 can distinguish isolated PMR from PMR with GCA: A retrospective study regarding PMR and GCA in Japan2015 · 22 citations

AIに質問

Bookmark

View Full Paper